BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36087225)

  • 1. Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors.
    Sun H; Yan Z; Zhang S
    Int J Hematol; 2023 Jan; 117(1):134-136. PubMed ID: 36087225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are aberrant BCR--ABL transcripts more common than previously thought?
    Wilson GA; Vandenberghe EA; Pollitt RC; Rees DC; Goodeve AC; Peake IR; Reilly JT
    Br J Haematol; 2000 Dec; 111(4):1109-11. PubMed ID: 11167748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The e1a3
    Chen Z
    Hematology; 2023 Dec; 28(1):2186040. PubMed ID: 36912524
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.
    Egan DN; Beppu L; Radich JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):184-9. PubMed ID: 25300870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
    Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and clinical outcome of T315I mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myeloid leukemia].
    Wang J; Zhang Y; Zu Y; Li Z; Li M; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):110-4. PubMed ID: 27014979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia.
    Pavlovsky C; Chan O; Talati C; Pinilla-Ibarz J
    Future Oncol; 2019 Jan; 15(3):257-269. PubMed ID: 30251548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
    Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
    Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
    Hidaka M; Inokuchi K; Uoshima N; Takahashi N; Yoshida N; Ota S; Nakamae H; Iwasaki H; Watanabe K; Kosaka Y; Komatsu N; Meguro K; Najima Y; Eto T; Kondo T; Kimura S; Yoshida C; Ishikawa Y; Sawa M; Hata T; Horibe K; Iida H; Shimomura T; Dobashi N; Sugiura I; Makiyama J; Miyagawa N; Sato A; Ito R; Matsumura I; Kanakura Y; Naoe T
    Jpn J Clin Oncol; 2024 Feb; 54(2):153-159. PubMed ID: 37986553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.
    Jones D; Kamel-Reid S; Bahler D; Dong H; Elenitoba-Johnson K; Press R; Quigley N; Rothberg P; Sabath D; Viswanatha D; Weck K; Zehnder J
    J Mol Diagn; 2009 Jan; 11(1):4-11. PubMed ID: 19095773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS; Greene JM; McConnell TS; Willman CL
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
    Bock O; Reising D; Kreipe H
    Diagn Mol Pathol; 2003 Sep; 12(3):119-23. PubMed ID: 12960692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Seymour JF; Kim DW; Rubin E; Haregewoin A; Clark J; Watson P; Hughes T; Dufva I; Jimenez JL; Mahon FX; Rousselot P; Cortes J; Martinelli G; Papayannidis C; Nagler A; Giles FJ
    Blood Cancer J; 2014 Aug; 4(8):e238. PubMed ID: 25127392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Philadelphia chromosome 30 years later].
    Lisker R
    Rev Invest Clin; 1992; 44(1):123-30. PubMed ID: 1523343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
    Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.